Literature DB >> 30872301

Imported malaria: key messages in an era of elimination.

Tommy Rampling1, Colin J Sutherland2, Christopher Jm Whitty3.   

Abstract

Despite concerted efforts to eliminate malaria, it remains a major global cause of morbidity and mortality with over 200 million annual cases. Significant gains have been made, with the annual global malaria incidence and mortality halving over the past twenty years, using tools such as long-lasting insecticide-treated bed nets and artemisinin-based therapies. Malaria is also a significant cause of life-threatening imported infection in the UK. It is vital for front line clinical staff involved in the assessment of acutely ill patients to be aware of the need for early diagnostic testing, malaria epidemiology, markers of severe infection and developments in antimalarial treatments to optimise patient management. The difference between a good and poor outcome is early diagnosis and treatment. Many of the challenges faced in the quest for global eradication, such as availability of appropriate diagnostic tests, and drug and insecticide resistance could also have future implications for imported malaria. © Royal College of Physicians 2019. All rights reserved.

Entities:  

Keywords:  Malaria; imported infection; malaria elimination

Year:  2019        PMID: 30872301      PMCID: PMC6454370          DOI: 10.7861/clinmedicine.19-2-153

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  15 in total

Review 1.  The past, present and future of childhood malaria mortality in Africa.

Authors:  R W Snow; J F Trape; K Marsh
Journal:  Trends Parasitol       Date:  2001-12

Review 2.  Vaccines against malaria.

Authors:  Amed Ouattara; Matthew B Laurens
Journal:  Clin Infect Dis       Date:  2014-12-01       Impact factor: 9.079

3.  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Authors: 
Journal:  Lancet       Date:  2015-04-23       Impact factor: 79.321

Review 4.  Malaria diagnostics: now and the future.

Authors:  Peter L Chiodini
Journal:  Parasitology       Date:  2014-09-12       Impact factor: 3.234

5.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

6.  Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study.

Authors:  Anna M Checkley; Adrian Smith; Valerie Smith; Marie Blaze; David Bradley; Peter L Chiodini; Christopher J M Whitty
Journal:  BMJ       Date:  2012-03-27

7.  Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study.

Authors:  Claire Broderick; Behzad Nadjm; Valerie Smith; Marie Blaze; Anna Checkley; Peter L Chiodini; Christopher J M Whitty
Journal:  BMJ       Date:  2015-04-16

8.  pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

Authors:  Colin J Sutherland; Paul Lansdell; Mandy Sanders; Julian Muwanguzi; Donelly A van Schalkwyk; Harparkash Kaur; Debbie Nolder; Julie Tucker; Hayley M Bennett; Thomas D Otto; Matthew Berriman; Trupti A Patel; Roderick Lynn; Effrossyni Gkrania-Klotsas; Peter L Chiodini
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two factorial design trial.

Authors:  Natacha Protopopoff; Jacklin F Mosha; Eliud Lukole; Jacques D Charlwood; Alexandra Wright; Charles D Mwalimu; Alphaxard Manjurano; Franklin W Mosha; William Kisinza; Immo Kleinschmidt; Mark Rowland
Journal:  Lancet       Date:  2018-04-11       Impact factor: 202.731

10.  UK malaria treatment guidelines 2016.

Authors:  David G Lalloo; Delane Shingadia; David J Bell; Nicholas J Beeching; Christopher J M Whitty; Peter L Chiodini
Journal:  J Infect       Date:  2016-02-12       Impact factor: 6.072

View more
  1 in total

1.  The risk of malaria infection for travelers visiting the Brazilian Amazonian region: A mathematical modeling approach.

Authors:  Eduardo Massad; Gabriel Zorello Laporta; Jan Evelyn Conn; Leonardo Suveges Chaves; Eduardo Sterlino Bergo; Elder Augusto Guimarães Figueira; Francisco Antonio Bezerra Coutinho; Luis Fernandez Lopez; Claudio Struchiner; Maria Anice Mureb Sallum
Journal:  Travel Med Infect Dis       Date:  2020-08-06       Impact factor: 6.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.